Changes in matrix metalloproteinase expression in SN-38 resistant colorectal cancer cells

被引：0
|
作者：
Berg, Spencer I. T. [1 ]
Cutler, Murray J., Jr. [1 ]
Blay, Jonathan [1 ]
机构：
[1] Univ Waterloo, Waterloo, ON N2L 3G1, Canada
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷
关键词：
D O I：
10.1158/1557-3265.PMS14-A04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A04
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ABCG2 is upregulated in SN-38 resistant colorectal cancer cells
    Costich, Tara L.
    Sill, Kevin
    Rios-Doria, Jonathan
    CANCER RESEARCH, 2011, 71
  • [2] In vitro cytotoxicity of chemoradiation with SN-38 in human colorectal cancer cells.
    Balcer-Kubiczek, E
    Wood, A
    Kennedy, AS
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3807S - 3807S
  • [3] Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells
    Takigawa, Nagio
    Takeyama, Masami
    Kozuki, Toshiyuki
    Shibayama, Takuo
    Hisamoto, Akiko
    Kiura, Katsuyuki
    Tada, Atsuhiko
    Hotta, Katsuyuki
    Umemura, Shigeki
    Ohashi, Kadoaki
    Fujiwara, Yoshiro
    Takata, Saburo
    Ichihara, Eiki
    Osawa, Masahiro
    Tabata, Masahiro
    Tanimoto, Mitsune
    Takahashi, Kiyoshi
    ONCOLOGY REPORTS, 2007, 17 (05) : 983 - 987
  • [4] Pregnane × Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
    Caroline Raynal
    Jean-Marc Pascussi
    Géraldine Leguelinel
    Cyril Breuker
    Jovana Kantar
    Benjamin Lallemant
    Sylvain Poujol
    Caroline Bonnans
    Dominique Joubert
    Frédéric Hollande
    Serge Lumbroso
    Jean-Paul Brouillet
    Alexandre Evrard
    Molecular Cancer, 9
  • [5] Pregnane x Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
    Raynal, Caroline
    Pascussi, Jean-Marc
    Legueline, Geraldine
    Breuker, Cyril
    Kantar, Jovana
    Lallemant, Benjamin
    Poujol, Sylvain
    Bonnans, Caroline
    Joubert, Dominique
    Hollande, Frederic
    Lumbroso, Serge
    Brouillet, Jean-Paul
    Evrard, Alexandre
    MOLECULAR CANCER, 2010, 9
  • [6] Combined efficacy of trifluridine and SN-38 in a 5-FU-resistant human colorectal cancer cell line
    Matsuoka, Kazuaki
    Kobunai, Takashi
    Takechi, Teiji
    CANCER RESEARCH, 2016, 76
  • [7] Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients
    Atasilp, Chalirmporn
    Chansriwong, Pichai
    Sirachainan, Ekapob
    Reungwetwattana, Thanyanan
    Puangpetch, Apichaya
    Prommas, Santirhat
    Sirilerttrakul, Suwannee
    Rerkarmnuaychoke, Budsaba
    Wongwaisayawan, Sansanee
    Sukasem, Chonlaphat
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (01)
  • [8] Analysis of irinotecan pharmacokinetics and of the metabolites SN-38 and SN-38 glucuronide in patients with cancer of the gastrointestinal tract
    Merkel, U
    Farker, K
    Wedding, U
    Rückert, M
    Hippius, M
    Höffken, K
    Hoffmann, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 713 - 714
  • [9] Combined efficacy and mechanism of trifluridine and SN-38 in a 5-FU-resistant human colorectal cancer cell lines
    Matsuoka, Kazuaki
    Takechi, Teiji
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (12): : 2577 - 2586
  • [10] SN-38 Overcomes Chemoresistance of Colorectal Cancer Cells Induced by Hypoxia, through HIF1alpha
    Murono, Koji
    Tsuno, Nelson H.
    Kawai, Kazushige
    Sasaki, Kazuhito
    Hongo, Kumiko
    Kaneko, Manabu
    Hiyoshi, Masaya
    Tada, Noriko
    Nirei, Takako
    Sunami, Eiji
    Takahashi, Koki
    Kitayama, Joji
    ANTICANCER RESEARCH, 2012, 32 (03) : 865 - 872
12345